Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
AJR Am J Roentgenol. 2010 Feb;194(2):414-21. doi: 10.2214/AJR.09.2892.
The purpose of our study was to determine whether (18)F-FDG PET/CT interpretation with metabolic-anatomic pattern analysis can be used to accurately assess for surgical staple line recurrence after colorectal cancer resection.
Seventy-nine consecutive patients with previous surgical resection of colorectal cancer were studied retrospectively. The surgical anastomotic or Hartmann's pouch staple lines were evaluated for presence or absence of tumor recurrence with FDG PET/CT metabolic-anatomic pattern analysis. Focal, eccentric, or perianastomotic CT masses with any associated PET pattern were regarded as positive for staple line recurrence. If the perianastomotic CT abnormality was presacral in location, then FDG uptake at least as intense as normal liver was required for positive interpretation. Eccentric or perianastomotic PET patterns matched with normal or diffuse thickening CT patterns were regarded as indeterminate. Presence or absence of recurrent tumor was confirmed by pathology, surgery, colonoscopy, imaging follow-up of at least 3 months, or clinical follow-up of at least 1 year.
Nine patients (11.4%) had staple line recurrence and 70 (88.6%) did not. FDG PET/CT interpretation yielded sensitivity, specificity, positive predictive value, negative predictive value, and accuracy results of 100% (9/9), 97.1% (68/70), 81.8% (9/11), 100% (68/68), and 97.5% (77/79), respectively. All nine patients with staple line recurrence showed perianastomotic or eccentric masses on CT, eight with matching perianastomotic or eccentric FDG uptake patterns. Background, diffuse, curvilinear, or focal FDG uptake patterns, regardless of FDG uptake intensity, paired with normal findings or diffuse mural thickening on CT were seen only in patients without staple line recurrence.
FDG PET/CT pattern analysis enables accurate assessment for staple line recurrence in patients with previous resection of colorectal cancer. The most reliable PET/CT pattern predicting staple line recurrence is an eccentric or perianastomotic mass on CT with corresponding eccentric or perianastomotic FDG uptake on PET. Background, diffuse (on one or both sides of the staple line), curvilinear, and focal patterns of FDG uptake do not correlate with recurrence in the absence of a mass on CT.
我们研究的目的是确定(18)F-FDG PET/CT 代谢-解剖模式分析是否可用于准确评估结直肠癌切除术后吻合口复发。
回顾性研究了 79 例先前接受结直肠癌手术切除的连续患者。通过 FDG PET/CT 代谢-解剖模式分析评估吻合口或 Hartmann 袋吻合口处是否存在肿瘤复发。吻合口周围 CT 上有局灶性、偏心性或吻合口周围 CT 肿块,且伴有任何 PET 模式者,被视为吻合口复发阳性。如果吻合口周围 CT 异常位于骶前,则吻合口周围 CT 异常需要至少与正常肝脏一样强烈的 FDG 摄取,方可进行阳性解读。偏心性或吻合口周围 PET 模式与正常或弥漫性增厚 CT 模式相匹配的,被视为不确定。通过病理、手术、结肠镜检查、至少 3 个月的影像学随访或至少 1 年的临床随访来证实是否存在复发性肿瘤。
9 例(11.4%)患者吻合口复发,70 例(88.6%)患者未复发。FDG PET/CT 解读的敏感性、特异性、阳性预测值、阴性预测值和准确率分别为 100%(9/9)、97.1%(68/70)、81.8%(9/11)、100%(68/68)和 97.5%(77/79)。所有 9 例吻合口复发患者 CT 上均显示吻合口周围或偏心性肿块,8 例患者吻合口周围或偏心性 FDG 摄取模式与之匹配。仅在没有吻合口复发的患者中,可见背景、弥漫性、曲线状或局灶性 FDG 摄取模式,无论 FDG 摄取强度如何,与 CT 上正常发现或弥漫性壁增厚相匹配。
FDG PET/CT 模式分析可准确评估结直肠癌切除术后吻合口复发。预测吻合口复发最可靠的 PET/CT 模式是 CT 上的偏心性或吻合口周围肿块,伴有 PET 上相应的偏心性或吻合口周围 FDG 摄取。在 CT 上无肿块的情况下,背景、弥漫性(在吻合口的一侧或两侧)、曲线状和局灶性 FDG 摄取模式与复发无关。